PUBLIC COMPANY
save$OVIDOvid Therapeutics Inc.
$OVID2.83000.00%New York, NY, USupdated 38m ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
2
marketed
0
phase 3
0
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Apr 7, 26grantPAPADOPOULOS STELIOS · 17,578 sh
- Apr 7, 26grantFitzgerald Kevin Joseph · 17,578 sh
- Apr 7, 26grantFriedman Bart · 8,789 sh
- Mar 23, 26option exerciseLEVIN JEREMY M · Executive Chairman47,333 sh
- Mar 23, 26option exerciseLEVIN JEREMY M · Executive Chairman47,333 sh
- Feb 26, 26grantFitzgerald Kevin Joseph · 65,000 sh
🐶 Hiring Signal
News
- Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCoAbout 26 months after failing two Phase 3 trials, an epilepsy treatment candidate is getting plucked off biopharma's shelves and will be given a new chance at life. Life sciences investment firm Pe…endpoints · 3d ago
- FDA’s leadership void leaves biotech with renewed ‘uncertainty’Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.biopharma_dive · 3mo ago
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that